In Reference to: "Cost and Utility of Thrombophilia Testing"
- PMID: 29056884
- PMCID: PMC5647890
- DOI: 10.12788/jhm.2818
In Reference to: "Cost and Utility of Thrombophilia Testing"
Comment in
-
Letter to the Editor, The Authors Reply: "Cost and Utility of Thrombophilia Testing".J Hosp Med. 2017 Sep;12(9):784. doi: 10.12788/jhm.2822. J Hosp Med. 2017. PMID: 29190304
Comment on
-
Inpatient inherited thrombophilia testing.J Hosp Med. 2016 Nov;11(11):801-804. doi: 10.1002/jhm.2616. J Hosp Med. 2016. PMID: 27782379 Review. No abstract available.
References
-
- Petrilli CM, Heidemann L, Mack M, Durance P, Chopra V. Inpatient inherited thrombophilia testing. J Hosp Med. 2016;11(11):801–804. - PubMed
-
- Abramson N, Abramson S. Hypercoagulability: clinical assessment and treatment. South Med J. 2001;94(10):1013–1020. - PubMed
-
- Somma J, Sussman II, Rand JH. An evaluation of thrombophilia screening in an urban tertiary care medical center: A “real world” experience. Am J Clin Pathol. 2006;126(1):120–127. - PubMed
-
- Centers for Medicare and Medicaid Services. [Accessed December 20, 2016];Clinical Laboratory Fee Schedule. 2016 https://www.cms.gov/Medicare/Medicare-fee-for-service-Payment/clinicalla....
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources